MRC1 and glioblastoma: Activation of MerTK, a receptor tyrosine kinase, polarizes GAMs to an immunosuppressive phenotype, but inhibition of MerTK from GAMs decreases immunosuppressive CD206+ GAM phenotype, leading to prolonged survival in GBM mouse models (Figure 1B) (46).